Monika M.
- Country
- Czechia
- Department
- Ambulantní péče v oboru hematologie a transfúzní péče
Research Overview
- 22104: A Randomized, Double-blind, Placebo-controlled, Multicenter Phase 2b/3 Study to Evaluate the Efficacy and Safety of Izokibep in Subjects with Active Psoriatic Arthritis
- A Randomized, Multi-regional, Double-blind, Double-dummy Parallel-group, Placebo and Allopurinol-controlled Phase 3 Study to Assess the Efficacy and Safety of Tigulixostat in Gout Patients with Hyperuricemia
Data & Insights
Has run more than one trial at 8 of 109 partner sites.
Specializations
Rheumatology Focus
This investigator specializes in treating inflammatory joint conditions, with particular emphasis on psoriatic arthritis management and therapeutic interventions.
- Advanced Psoriatic Arthritis Treatment
- Inflammatory Joint Disease Management
- Novel Therapeutic Approaches
The investigator evaluates innovative therapeutic agents targeting specific pathways in inflammatory arthritis conditions.
Metabolic Disorders
The investigator focuses on metabolic conditions affecting joint health, particularly hyperuricemia and its manifestations in gout.
- Gout Management Strategies
- Uric Acid Control
- Comparative Treatment Studies
Their work includes evaluation of therapeutic approaches for managing hyperuricemia in gout patients.
Treatment Innovation
The investigator examines comparative effectiveness of both established and emerging therapeutics in rheumatic conditions.
- Novel Treatment Evaluation
- Therapeutic Efficacy Assessment
- Clinical Response Monitoring
Their research encompasses evaluation of treatment responses in chronic rheumatic conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.